4.8 Editorial Material

Patient-derived explants as tumor models

Journal

CANCER CELL
Volume 40, Issue 4, Pages 348-350

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2022.03.004

Keywords

-

Funding

  1. NIH [CA197718, NS103434, CA238662]

Ask authors/readers for more resources

Tumors are dynamic ecosystems with heterogeneous neoplastic cells and diverse stromal elements, posing challenges for ex vivo predictive modeling. Single-cell analysis reveals that patient-derived explants can replicate the diversity of tumor cells and transient stromal cell types found in patient surgical specimens, suggesting their value as tumor models.
Tumors contain heterogeneous neoplastic cells and diverse stromal elements that collectively function as dynamic ecosystems, and this complicates predictive modeling ex vivo. LeBlanc et al. utilize single-cell analysis to demonstrate that patient-derived explants replicate tumor cell diversity and transient stromal cell types in patient surgical specimens. This suggests that patient-derived explants can be valuable as tumor models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available